- Home
- CAAP vs RXRX Comparison
CAAP vs RXRX Comparison
Compare CAAP & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- RXRX
- Stock Information
- Founded
- CAAP 1998
- RXRX 2013
- Country
- CAAP Luxembourg
- RXRX United States
- Employees
- CAAP N/A
- RXRX N/A
- Industry
- CAAP Aerospace
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- CAAP Consumer Discretionary
- RXRX Health Care
- Exchange
- CAAP Nasdaq
- RXRX Nasdaq
- Market Cap
- CAAP 2.9B
- RXRX 2.6B
- IPO Year
- CAAP 2018
- RXRX 2021
- Fundamental
- Price
- CAAP $23.16
- RXRX $4.73
- Analyst Decision
- CAAP Strong Buy
- RXRX Buy
- Analyst Count
- CAAP 2
- RXRX 4
- Target Price
- CAAP $24.60
- RXRX $7.25
- AVG Volume (30 Days)
- CAAP 193.4K
- RXRX 54.9M
- Earning Date
- CAAP 11-19-2025
- RXRX 11-05-2025
- Dividend Yield
- CAAP N/A
- RXRX N/A
- EPS Growth
- CAAP N/A
- RXRX N/A
- EPS
- CAAP 0.93
- RXRX N/A
- Revenue
- CAAP $1,873,095,000.00
- RXRX $43,689,000.00
- Revenue This Year
- CAAP $4.43
- RXRX $24.17
- Revenue Next Year
- CAAP $7.32
- RXRX $20.96
- P/E Ratio
- CAAP $24.66
- RXRX N/A
- Revenue Growth
- CAAP 26.88
- RXRX N/A
- 52 Week Low
- CAAP $15.01
- RXRX $3.79
- 52 Week High
- CAAP $23.43
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- CAAP 75.05
- RXRX 39.28
- Support Level
- CAAP $21.67
- RXRX $4.46
- Resistance Level
- CAAP $22.36
- RXRX $4.96
- Average True Range (ATR)
- CAAP 0.63
- RXRX 0.38
- MACD
- CAAP 0.20
- RXRX -0.15
- Stochastic Oscillator
- CAAP 93.66
- RXRX 20.04
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.